TNGX News and Press, Tango Therapeutics Inc. From 08/28/23

Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations Mr. Caravella’s appointment demonstrates Medicenna’s continuing commitment to establish its presence in Boston, ...

2023-08-17 05:05:00 ET On Aug. 7, Tango Therapeutics (NASDAQ: TNGX) reported its second-quarter earnings, and by Aug. 11, its shares were up by a shocking 126%. Its earnings update didn't make any waves; this is a pre-revenue biotech company, and it didn't report any stunningly posi...

2023-08-14 08:32:23 ET AMC Entertainment Holdings ( AMC ) -33% . BioXcel Therapeutics BTAI -32% after Q2 earning release . Bridgeline Digital BLIN -19% after Q3 earning release . Black Spade Acquisition Co ( BSAQ ) -16% . Fortrea Holdings FT...

2023-08-10 16:52:14 ET Shares of Tango Therapeutics (NASDAQ: TNGX) were up more than 91% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech company's stock closed last week at $3.40 and reached a...

2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...

2023-08-10 07:30:00 ET Summary Tango Therapeutics is advancing in cancer treatment with Phase 1/2 clinical trials for TNG908 and TNG462, targeting MTAP-deleted tumors. Tango's stock soared by over 100% following Mirati's announcement on their unique PRMT5 inhibitor, emphasizing po...

2023-08-10 07:24:00 ET Clinical-stage biotechnology Tango Therapeutics ( NASDAQ: TNGX ) down 15% as the company will sell ~15.5M shares at a per share price of $5.15. The financing is expected to close on Friday, August 11, 2023. Gross proceeds from the private pla...

BOSTON, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, has agreed to sell approximately 15.5 million shares of its common stock (“Co...

2023-08-09 13:27:46 ET Gainers: Benitec Biopharma ( BNTC ) +81% . Tango Therapeutics ( TNGX ) +77% . Decibel Therapeutics ( DBTX ) +76% . T Stamp ( IDAI ) +50% . Millennium Group International Holdings ( MGIH ) +43% . EBET ( ...

2023-08-09 10:08:11 ET Gainers: Tango Therapeutics ( TNGX ) +137% . Decibel Therapeutics ( DBTX ) +72% . Mirati Therapeutics ( MRTX ) +26% . Azenta ( AZTA ) +25% . Clover Health Investments ( CLOV ) +18 % . Losers: ...